Research Article
Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Diet-Induced Metabolic Syndrome in Rats
Table 1
Physiological parameters of CS-, HCHF-, CS +
t-AUCB-, HCHF +
t-AUCB-treated rats. *
versus CS-fed rats; **
versus HCHF-fed rats.
| Parameter | CS (16 weeks) | HCHF (16 weeks) | CS + t-AUCB (16 weeks) | HCHF + t-AUCB (16 weeks) |
| Body weight @ week 16 (g) | 422 ± 6 () | 515.8 ± 11.9 () | 415 ± 6 () | 515.7 ± 13 () | Abdominal fat deposition (mg/mm tibial length) | 401 ± 56 () | 746 ± 67* () | 270 ± 38 () | 674 ± 99* () | Total fat mass (g) | 56 ± 5 () | 139.4 ± 16* () | 46.7 ± 8 () | 154.3 ± 19* () | Heart rate (bpm) | 249 ± 9 () | 251 ± 21 () | 262 ± 13 () | 265 ± 8 () | LVIDd (mm) | 6.73 ± 0.2 () | 7.54 ± 0.18* () | 6.8 ± 0.2** () | 6.8 ± 0.2** () | LVPWd (mm) | 1.69 ± 0.1 () | 1.95 ± 0.1 () | 1.69 ± 0.08 () | 1.9 ± 0.1 () | LVIDs (mm) | 3.9 ± 0.3 () | 4.9 ± 0.2* () | 3.6 ± 0.2** () | 4.2 ± 0.2** () | E/A ratio | 1.6 ± 0.1 () | 1.2 ± 0.1* () | 2.0 ± 0.2** () | 1.5 ± 0.04** () | Ejection fraction (%) | 79 ± 4 () | 72 ± 2 () | 85 ± 2** () | 76 ± 3 () | Cardiac output (mL/min) | 63.4 ± 6.4 () | 83.8 ± 9 () | 81.8 ± 10 () | 72.2 ± 7 () | Estimated LV mass (g) | 0.74 ± 0.05 () | 1.0 ± 0.05* () | 0.77 ± 0.05** () | 0.84 ± 0.04** () | Diastolic stiffness constant (κ) | 20.5 ± 1.9 () | 28.9 ± 1* () | 22.8 ± 0.4** () | 20.1 ± 0.1** () | Plasma insulin concentrations | 2.2 ± 0.4 () | 4.2 ± 0.3* () | 4.7 ± 1.1* () | 5.2 ± 1* () | Plasma leptin concentrations | 6.8 ± 0.86 () | 8.6 ± 1.1 () | 6.9 ± 0.8 () | 9.7 ± 0.5 () | Plasma ALT activity, U/L | 37 ± 0.6 () | 59.6 ± 0.3* () | 52.3 ± 2* () | 49.4 ± 3.2* () | Plasma AST activity, U/L | 73.2 ± 5.6 () | 105.3 ± 9* () | 68.2 ± 3.2** () | 69.7 ± 5.7** () | Plasma ALP activity, U/L | 174 ± 19 () | 251 ± 21* () | 192 ± 11** () | 274 ± 29* () | Plasma LDH activity, U/L | 204 ± 23 () | 497 ± 14* () | 180 ± 56** () | 184 ± 26** () | LV + septum (mg/mm tibial length) | 18.9 ± 0.9 () | 21.8 ± 1.1 () | 20.3 ± 1.5 () | 20.5 ± 0.8 () | Right ventricle (mg/mm tibial length) | 4.14 ± 0.3 () | 4.48 ± 0.3 () | 3.7 ± 0.2 () | 4.4 ± 0.3 () | Liver (mg/mm tibial length) | 234 ± 14 () | 287 ± 12* () | 264 ± 15 () | 292 ± 19* () | Islets as % area of pancreas | 6.2 ± 1.4 () | 15.3 ± 1.5 () | 5.2 ± 0.1 () | 16.7 ± 1.3 () | Number of α cells/islet | 16.9 ± 0.5
| 39.3 ± 1.2
| 22.4 ± 1.9
| 38.6 ± 1.4 () | Number of β cells/islet | 72.3 ± 2.8 () | 124.7 ± 7.2 () | 117.1 ± 4.1 () | 149.8 ± 6.3 () |
|
|